Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Contrarian Investing -- Ignore unavailable to you. Want to Upgrade?

To: pcyhuang who wrote (692)	1/9/2007 7:51:24 PM
From: MJ	Respond to of 4080

Appreciated you messages on BSX. "New uses for the underlying technology in defibrillators could include treatment of severe mi graines and other maladies, which could be a catalyst for sales once clinical trials proving their effectiveness are complete, analysts said. Until then, ICD makers are funding education and training efforts to convince more doctors to issue referrals for surgical implants. As part of that plan, Boston Scientific last month launched an ad campaign touting its cardiac-device business..." Migraines can be debilitating-----if this is a use that can give people, predominantly women, back their lives can see that there may be demand. Reg. stents--------my brother is alive and active 11 years after having a stent put in due to a heart attack. Eliminated all milk products, watches diet and has a second career in his 60's. When the stock collapsed I did not know the reasons. Now I know. mj